J. Mayes

发表

Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation.

D. Moreira, V. Mouraviev, T. Polascik, 2010, Urology.

Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer

J. Moul, J. Madden, V. Mouraviev, 2007, Cancer.

Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy.

J. Moul, J. Madden, V. Mouraviev, 2007, Urology.

Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?

J. Moul, V. Mouraviev, T. Polascik, 2008, Urology.

Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer

V. Mouraviev, T. Polascik, T. Polascik, 2009, International Journal of Impotence Research.

Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor.

R. Nelson, V. Mouraviev, T. Polascik, 2008, Journal of endourology.

Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney.

V. Mouraviev, T. Polascik, J. Mayes, 2008, Urology.

Short Term Clinical Outcome after Laparoscopic Cryoablation of the Renal Tumor ≤ 3.5 cm

V. Mouraviev, T. Polascik, J. Mayes, 2007, Technology in cancer research & treatment.

Nerve-sparing focal cryoablation of prostate cancer

V. Mouraviev, T. Polascik, J. Mayes, 2009, Current opinion in urology.

Utilization of 111In‐Capromab pendetide SPECT‐CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy

J. Madden, V. Mouraviev, T. Polascik, 2009, International journal of urology : official journal of the Japanese Urological Association.

Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended

V. Mouraviev, T. Polascik, M. Kimura, 2010, BJU international.

Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy

V. Mouraviev, T. Polascik, T. Satoh, 2010, BJU international.

Patient selection for hemiablative focal therapy of prostate cancer

J. Moul, J. Madden, V. Mouraviev, 2009, Cancer.

Pathologic basis of focal therapy for early-stage prostate cancer

V. Mouraviev, T. Polascik, J. Mayes, 2009, Nature Reviews Urology.

The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma.

J. Madden, V. Mouraviev, T. Polascik, 2008, Journal of endourology.

Altered male physiologic function after surgery for prostate cancer: couple perspective.

V. Mouraviev, T. Polascik, T. Krupski, 2009, International braz j urol : official journal of the Brazilian Society of Urology.

WITHDRAWN: Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer?

J. Madden, T. Polascik, J. Mayes, 2008, Prostate cancer and prostatic diseases.

Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapy

J. Moul, J. Madden, V. Mouraviev, 2008, The Prostate.

Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation.

V. Mouraviev, T. Polascik, M. Kimura, 2009, Urology.

Utility of a 3-Dimensional Transrectal Ultrasound-guided Prostate Biopsy System for Prostate Cancer Detection

J. Moul, J. Madden, V. Mouraviev, 2009, Technology in cancer research & treatment.

Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy.

J. Moul, J. Madden, V. Mouraviev, 2009, Urology.

Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.

J. Moul, M. Anscher, V. Mouraviev, 2008, International journal of radiation oncology, biology, physics.

Analysis of Laterality and Percentage of Tumor Involvement in 1386 Prostatectomized Specimens for Selection of Unilateral Focal Cryotherapy

J. Madden, V. Mouraviev, T. Polascik, 2007, Technology in cancer research & treatment.

Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.

V. Mouraviev, T. Polascik, J. Mayes, 2007, Urology.

From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer.

V. Mouraviev, T. Polascik, J. Mayes, 2008, Oncology.

Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

J. Madden, V. Mouraviev, T. Polascik, 2011, Urologic oncology.

Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland.

J. Madden, V. Mouraviev, T. Polascik, 2009, The Journal of urology.